Puriblood Medical Co., Ltd. (TPEX:6847)
58.30
+8.60 (17.30%)
Apr 29, 2026, 1:36 PM CST
Puriblood Medical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Market Capitalization | 830 | 1,430 | 1,601 | 1,928 | 2,305 | - | Upgrade
|
| Market Cap Growth | -41.52% | -10.67% | -16.97% | -16.36% | - | - | Upgrade
|
| Enterprise Value | 804 | 1,382 | 1,562 | 1,867 | 2,169 | - | Upgrade
|
| Last Close Price | 58.30 | 100.50 | 112.50 | 135.50 | 162.00 | - | Upgrade
|
| PE Ratio | - | - | - | 116.62 | - | - | Upgrade
|
| PS Ratio | 7.07 | 12.92 | 12.78 | 14.03 | 42.23 | - | Upgrade
|
| PB Ratio | 5.08 | 8.15 | 8.84 | 8.27 | 10.65 | - | Upgrade
|
| P/TBV Ratio | 5.36 | 8.63 | 9.49 | 8.86 | 11.11 | - | Upgrade
|
| P/FCF Ratio | - | - | 78.48 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 60.08 | - | - | - | Upgrade
|
| EV/Sales Ratio | 6.85 | 12.49 | 12.47 | 13.59 | 39.73 | - | Upgrade
|
| EV/EBITDA Ratio | 236.02 | 348.23 | - | 138.76 | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | 257.98 | - | - | Upgrade
|
| EV/FCF Ratio | -32.38 | - | 76.56 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.34 | 0.30 | 0.28 | 0.24 | 0.14 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 6.76 | 9.55 | - | 3.80 | - | 22.17 | Upgrade
|
| Debt / FCF Ratio | - | - | 2.53 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.16 | -0.20 | -0.36 | -0.18 | -0.47 | -0.46 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.91 | -8.76 | 1.50 | -3.19 | 3.32 | -970.22 | Upgrade
|
| Net Debt / FCF Ratio | 1.05 | 1.10 | -3.23 | 1.30 | 2.17 | 3.39 | Upgrade
|
| Asset Turnover | 0.47 | 0.42 | 0.43 | 0.47 | 0.24 | 0.27 | Upgrade
|
| Inventory Turnover | 1.37 | 1.75 | 4.31 | 3.27 | 4.31 | 3.26 | Upgrade
|
| Quick Ratio | 1.77 | 2.80 | 3.16 | 3.41 | 6.41 | 7.04 | Upgrade
|
| Current Ratio | 2.81 | 3.81 | 3.88 | 5.81 | 7.99 | 7.42 | Upgrade
|
| Return on Equity (ROE) | -4.50% | -3.01% | -24.91% | 7.36% | -21.09% | -3.25% | Upgrade
|
| Return on Assets (ROA) | 0.04% | -0.65% | -10.75% | 1.54% | -9.58% | -1.46% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.12% | -2.14% | -33.00% | 4.63% | -36.66% | -4.93% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.10% | -1.20% | -22.30% | 2.50% | -14.50% | -1.80% | Upgrade
|
| Earnings Yield | -0.90% | -0.38% | -3.22% | 0.86% | -1.65% | - | Upgrade
|
| FCF Yield | -2.99% | -2.22% | 1.27% | -1.71% | -2.03% | - | Upgrade
|
| Buyback Yield / Dilution | - | - | - | -22.10% | -35.52% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.